Maximum quantity allowed is 999
请选择数量
CAS RN: 322-79-2 | 產品號碼: T3601
| 產品號碼 | T3601 |
| 純度/分析方法 | >98.0%(T) |
| 分子式 / 分子量 | C__1__0H__7F__3O__4 = 248.16 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Refrigerated (0-10°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器 | 250MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 322-79-2 |
| Reaxys-RN | 2945374 |
| PubChem Substance ID | 354335089 |
| Merck Index(14) | 9688 |
| MDL編號 | MFCD00866793 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 96.0 % |
| Purity(Neutralization titration) | min. 98.0 % |
| Melting point | 113.0 to 117.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 115 °C |
| Maximum Wavelength | 297 nm (H__2O) |
| 水溶性 | Insoluble |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
運輸資料
| HS編碼* | 2918.29-000 |
Application
Triflusal: An Antiplatelet Aggregation Agent
Triflusal is an antiplatelet aggregation agent having a trifluoromethyl group at the 4-position. It is metabolized to 2-hydroxy-4-trifluoromethylbenzoic acid (HTB) which inhibits cyclogxygenase-1 (COX-1) in platelets. Furthermore, both triflusal and HTB are also able to increase cyclic adenosine monophosphate (cAMP) [A2381] levels in platelets through inhibition of platelet phosphodiesterases which regulate intracellular cAMP levels. Moreover, triflusal enhances the production of NO by neutrophils via stimulation of the constitutive activity of nitric oxide (NO) synthase (cNOS). It is considered that triflusal shows the antiplatelet aggregation activity by these actions. (The product is for research purpose only.)
References
- Triflusal: An Old Drug in Modern Antiplatelet Therapy. Review of Its Action, Use, Safety and Effectiveness
- Determination of triflusal in human plasma by high performance liquid chromatography with automated column switching system
- Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography
考研文獻
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。